Antagonistic Cross-Regulation between Sox9 and Sox10 Controls an Anti-tumorigenic Program in Melanoma
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Melanoma is the most fatal skin cancer, but the etiology of this devastating disease is still poorly understood. Recently, the transcription factor Sox10 has been shown to promote both melanoma initiation and progression. Reducing SOX10 expression levels in human melanoma cells and in a genetic melanoma mouse model, efficiently abolishes tumorigenesis by inducing cell cycle exit and apoptosis. Here, we show that this anti-tumorigenic effect functionally involves SOX9, a factor related to SOX10 and upregulated in melanoma cells upon loss of SOX10. Unlike SOX10, SOX9 is not required for normal melanocyte stem cell function, the formation of hyperplastic lesions, and melanoma initiation. To the contrary, SOX9 overexpression results in cell cycle arrest, apoptosis, and a gene expression profile shared by melanoma cells with reduced SOX10 expression. Moreover, SOX9 binds to the SOX10 promoter and induces downregulation of SOX10 expression, revealing a feedback loop reinforcing the SOX10 low/SOX9 high ant,m/ii-tumorigenic program. Finally, SOX9 is required in vitro and in vivo for the anti-tumorigenic effect achieved by reducing SOX10 expression. Thus, SOX10 and SOX9 are functionally antagonistic regulators of melanoma development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“we found amongst our top SALL4-HDAC2 shared de novo DNA binding motifs matches for known transcriptional regulators of the NC that are re-expressed and have functional implication in melanoma, such as SOX10 and SOX948 or RUNX149,50, and also key regulators of melanocyte differentiation and hence melanoma, such as MITF51 or TFAP2C52,53”
From Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4 (2021) · cites this paper as [48]
The cited source says what the claim attributes to it.
In the citing paper
“This is reminiscent of melanoma cells displaying reduced SOX10 levels, which is associated with increased expression of SOX9, another factor involved in NC development, and increased invasiveness48,71.”
From Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4 (2021) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stöckl, S., Göttl, C., Grifka, J., & Grässel, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350089 · Cited by 4,656
Rudin, C. M., Durinck, S., Stawiski, E. W., Poirier, J. T., Modrusan, Z., Shames, D. S., Bergbower, E. A., Guan, Y., Shin, J., Guillory, J., et al. (2012) · Nature Genetics · doi:10.1038/ng.2405 · Cited by 1,077
SOX9 directly regulates the type-ll collagen gene
Bell, D. M., Leung, K. K. H., Wheatley, S. C., Ng, L. J., Zhou, S., Wing Ling, K., Har Sham, M., Koopman, P., Tam, P. P. L., & Cheah, K. S. E. (1997) · Nature Genetics · doi:10.1038/ng0697-174 · Cited by 933 · cited 1×
“Moreover, while Sox9 activates the expression of genes involved in the induction of osteochondrogenesis in neural crest cells in pharyngeal arches [26,28,60], Sox10 is involved in the specification of a glial and melanocytic gene expression program [13].”
BackgroundThe Sox Family of Transcription Factors: Versatile Regulators of Stem and Progenitor Cell Fate
Sarkar, A., & Hochedlinger, K. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.12.007 · Cited by 920 · cited 1×
“Sox genes play key roles in embryonic development and are major determinants of stem cell behavior, regulating cell fate decisions and maintaining cellular identity [3].”
BackgroundThe transcription factor Sox10 is a key regulator of peripheral glial development
Britsch, S., Goerich, D. E., Riethmacher, D., Peirano, R. I., Rossner, M., Nave, K.-A., Birchmeier, C., & Wegner, M. (2001) · Genes & Development · doi:10.1101/gad.186601 · Cited by 914 · cited 2×
“Moreover, while Sox9 activates the expression of genes involved in the induction of osteochondrogenesis in neural crest cells in pharyngeal arches [26,28,60], Sox10 is involved in the specification of a glial and melanocytic gene expression program [13].”
BackgroundSelf-citationDominant role of the niche in melanocyte stem-cell fate determination
Nishimura, E. K., Jordan, S. A., Oshima, H., Yoshida, H., Osawa, M., Moriyama, M., Jackson, I. J., Barrandon, Y., Miyachi, Y., & Nishikawa, S.-I. (2002) · Nature · doi:10.1038/416854a · Cited by 901 · cited 1×
“Melanocyte stem cells are found in a specialized region of the hair follicle called bulge and give rise to melanocyte progenitors and differentiated melanocytes [42].”
BackgroundFrom head to toes: the multiple facets of Sox proteins
Wegner, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.6.1409 · Cited by 890 · cited 1×
“A common feature of SoxE group proteins, which includes Sox9 and Sox10, is their expression in neural crest (NC) cells during embryonic development [2, 11].”
BackgroundSelf-citationSOX10 mutations in patients with Waardenburg-Hirschsprung disease
Pingault, V., Bondurand, N., Kuhlbrodt, K., Goerich, D. E., Préhu, M.-O., Puliti, A., Herbarth, B., Hermans-Borgmeyer, I., Legius, E., Matthijs, G., et al. (1998) · Nature Genetics · doi:10.1038/ng0298-171 · Cited by 825
Self-citationda Silva, S. M., Hacker, A., Harley, V., Goodfellow, P., Swain, A., & Lovell-Badge, R. (1996) · Nature Genetics · doi:10.1038/ng0996-62 · Cited by 795
Mechanisms of hair graying: incomplete melanocyte stem cell maintenance in the niche
Nishimura, E. K., Granter, S. R., & Fisher, D. E. (2005) · Science · doi:10.1126/science.1099593 · Cited by 750 · cited 1×
“When melanocyte stem cells are functionally impaired, they fail to generate melanocytes, which results in hair graying [43].”
Background
Cited by
The role of SOX family members in solid tumours and metastasis
Grimm, D., Bauer, J., Wise, P., Krüger, M., Simonsen, U., Wehland, M., Infanger, M., & Corydon, T. J. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.03.004 · Cited by 487
Robust gene expression programs underlie recurrent cell states and phenotype switching in melanoma
Wouters, J., Kalender-Atak, Z., Minnoye, L., Spanier, K. I., De Waegeneer, M., Bravo González-Blas, C., Mauduit, D., Davie, K., Hulselmans, G., Najem, A., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0547-3 · Cited by 258
Epithelial‐to‐mesenchymal‐like transition events in melanoma
Pedri, D., Karras, P., Landeloos, E., Marine, J., & Rambow, F. (2022) · The FEBS Journal · doi:10.1111/febs.16021 · Cited by 126
Epigenetics of malignant melanoma
Moran, B., Silva, R., Perry, A. S., & Gallagher, W. M. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.10.006 · Cited by 142
Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma
Capparelli, C., Purwin, T. J., Glasheen, M. Q., Caksa, S., Tiago, M., Wilski, N. A., Pomante, D., Rosenbaum, S. R., Nguyen, M. Q., Cai, W., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28801-y · Cited by 109
Cheng, P. F., Shakhova, O., Widmer, D. S., Eichhoff, O. M., Zingg, D., Frommel, S. C., Belloni, B., Raaijmakers, M. I., Goldinger, S. M., Santoro, R., et al. (2015) · Genome Biology · doi:10.1186/s13059-015-0594-4 · Cited by 100
“The specificity of this assay was demonstrated by the enrichment of three known SOX9 target sequences, COL2A1 intron 1 [36], p21 [29], and SOX10 [37]), as compared to a non-target gene (IP10).”
ResultInfluentialSelf-citationRossi, A., Roberto, M., Panebianco, M., Botticelli, A., Mazzuca, F., & Marchetti, P. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172621 · Cited by 99
Cooperation between melanoma cell states promotes metastasis through heterotypic cluster formation
Campbell, N. R., Rao, A., Hunter, M. V., Sznurkowska, M. K., Briker, L., Zhang, M., Baron, M., Heilmann, S., Deforet, M., Kenny, C., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.08.018 · Cited by 89
Self-citationXu, X., Zhang, D., Kong, P., Gao, Y., Huang, X.-F., Song, Y., Zhang, W., Guo, R., Li, C., Chen, B., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112869 · Cited by 90
SOX9 Is Essential for Triple-Negative Breast Cancer Cell Survival and Metastasis
Ma, Y., Shepherd, J., Zhao, D., Bollu, L. R., Tahaney, W. M., Hill, J. L., Zhang, Y., Mazumdar, A., & Brown, P. H. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0311 · Cited by 96
Inflammation-Induced Plasticity in Melanoma Therapy and Metastasis
Hölzel, M., & Tüting, T. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.03.009 · Cited by 84
Ennen, M., Keime, C., Gambi, G., Kieny, A., Coassolo, S., Thibault-Carpentier, C., Margerin-Schaller, F., Davidson, G., Vagne, C., Lipsker, D. M., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0010 · Cited by 87
Schock, E. N., & LaBonne, C. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.606889 · Cited by 74
“For these variants, there is in vitro evidence that these elongated proteins Frontiers in Physiology | www.frontiersin.org 10 December 2020 | Volume 11 | Article 606889 have dominant negative effects (Inoue et al., 1999; Sham et al., 2001; Chan et al., 2003).”
BackgroundMelanoma Plasticity: Promoter of Metastasis and Resistance to Therapy
Huang, F., Santinon, F., González, R. E. F., & Rincon, S. V. D. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.756001 · Cited by 75
“For example, the switch in expression between pairs of closely related transcriptional regulators, such as ZEB2/ZEB1 (35–38), SOX10/SOX9 (32, 33), and LEF1/TCF4 (34), drive melanoma cells towards the proliferative and invasive phenotype, respectively.”
BackgroundTranscription factor Sox10 regulates oligodendroglial Sox9 levels via microRNAs
Reiprich, S., Cantone, M., Weider, M., Baroti, T., Wittstatt, J., Schmitt, C., Küspert, M., Vera, J., & Wegner, M. (2017) · Glia · doi:10.1002/glia.23146 · Cited by 63
“Similarly, during melanoma development, Sox10 is required for formation of hyperplastic lesions, and promotes tumorigenesis, whereas Sox9 causes cell cycle arrest and apoptosis, induces a differentiated expression profile and has an anti-tumorigenic effect (Shakhova et al. 2015).”
BackgroundSelf-citationRho-mediated signaling promotes BRAF inhibitor resistance in de-differentiated melanoma cells
Misek, S. A., Appleton, K. M., Dexheimer, T. S., Lisabeth, E. M., Lo, R. S., Larsen, S. D., Gallo, K. A., & Neubig, R. R. (2019) · Oncogene · doi:10.1038/s41388-019-1074-1 · Cited by 73
Ligand-activated BMP signaling inhibits cell differentiation and death to promote melanoma
Venkatesan, A. M., Vyas, R., Gramann, A. K., Dresser, K., Gujja, S., Bhatnagar, S., Chhangawala, S., Gomes, C. B. F., Xi, H. S., Lian, C. G., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92513 · Cited by 64
Mechanical confinement governs phenotypic plasticity in melanoma
Hunter, M. V., Joshi, E., Bowker, S., Montal, E. D., Ma, Y., Kim, Y. H., Yang, Z., Tuffery, L., Li, Z., Rosiek, E., et al. (2025) · Nature · doi:10.1038/s41586-025-09445-6 · Cited by 70
SOX-mediated molecular crosstalk during the progression of tumorigenesis
Xu, Y., & Yang, W. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.07.028 · Cited by 58
Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells
Testa, U., Castelli, G., & Pelosi, E. (2017) · Medical Sciences · doi:10.3390/medsci5040028 · Cited by 59
“SOX10 inactivation induces a marked upmodulation of SOX9, with consequent induction of cell cycle arrest and melanoma cell death [253].”
BackgroundIndependent Origin of XY and ZW Sex Determination Mechanisms in Mosquitofish Sister Species
Kottler, V. A., Feron, R., Nanda, I., Klopp, C., Du, K., Kneitz, S., Helmprobst, F., Lamatsch, D. K., Lopez‐Roques, C., Lluch, J., et al. (2020) · Genetics · doi:10.1534/genetics.119.302698 · Cited by 52
SOX9 is a dose-dependent metastatic fate determinant in melanoma
Yang, X., Liang, R., Liu, C., Liu, J. A., Cheung, M. P. L., Liu, X., Man, O. Y., Guan, X.-Y., Lung, H. L., & Cheung, M. C. H. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0998-6 · Cited by 50
Targeting the lncRNA SAMMSON Reveals Metabolic Vulnerability in Melanoma
Goding, C. R. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.04.010 · Cited by 47
“One possibility is that in SOX10-low cells, SAMMSON is regulated by an alternative SOX factor such as SOX9, known to play a key antagonistic role to SOX10 in melanoma (Shakhova et al., 2015).”
BackgroundRole of extracellular matrix architecture and signaling in melanoma therapeutic resistance
Popovic, A., & Tartare‐Deckert, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.924553 · Cited by 50
SOX10-MITF pathway activity in melanoma cells
Tudrej, K. B., Czepielewska, E., & Kozłowska−Wojciechowska, M. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.60655 · Cited by 50
Gelato, K. A., Schöckel, L., Klingbeil, O., Rückert, T., Lesche, R., Toedling, J., Kalfon, E., Héroult, M., Lejeune, P., Mönning, U., et al. (2017) · Oncogene · doi:10.1038/onc.2017.325 · Cited by 44
Identification and functional analysis of SOX10 phosphorylation sites in melanoma
Cronin, J. C., Loftus, S. K., Baxter, L. L., Swatkoski, S., Guček, M., & Pavan, W. J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190834 · Cited by 40
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion
Graf, S. A., Heppt, M. V., Wessely, A., Krebs, S., Kammerbauer, C., Hornig, E., Strieder, A., Blum, H., Bosserhoff, A., & Berking, C. (2018) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12760 · Cited by 56
Najem, A., Soumoy, L., Sabbah, M., Krayem, M., Awada, A. H., Journé, F., & Ghanem, G. (2022) · Cells · doi:10.3390/cells11071157 · Cited by 40
“These genes belong to the SOX (Sry (sex determining region Y)-related HMG box) family that plays a critical role in embryonic development and the regulation of cell fate [20].”
BackgroundCoste, C., Neirinckx, V., Sharma, A., Agirman, G., Rogister, B., Foguenne, J., Lallemend, F., Gothot, A., & Wislet‐Gendebien, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177962 · Cited by 39
“been demonstrated that, in some conditions, SOX10 expression could be down-regulated by SOX9 [58].”
Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4
Diener, J., Baggiolini, A., Pernebrink, M., Dalcher, D., Lerra, L., Cheng, P. F., Varum, S., Häusel, J., Stierli, S., Treier, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25326-8 · Cited by 34
Self-citationSOX5 is involved in balanced MITF regulation in human melanoma cells
Kordaß, T., Weber, C. E. M., Oswald, M., Ast, V., Bernhardt, M., Novak, D., Utikal, J. S., Eichmüller, S. B., & König, R. (2016) · BMC Medical Genomics · doi:10.1186/s12920-016-0170-0 · Cited by 37
SOX9 indirectly regulates CEACAM1 expression and immune resistance in melanoma cells
Ashkenazi, S., Ortenberg, R., Besser, M. J., Schachter, J., & Markel, G. (2016) · Oncotarget · doi:10.18632/oncotarget.7379 · Cited by 31
“In melanoma, previous works demonstrated that overexpression of SOX9 inhibits growth of melanoma cells and causes cell cycle arrest [22], [23].”
BackgroundRegulation of zebrafish melanocyte development by ligand-dependent BMP signaling
Gramann, A. K., Venkatesan, A. M., Guerin, M., & Ceol, C. J. (2019) · eLife · doi:10.7554/elife.50047 · Cited by 30
Expression and correlation of MALAT1 and SOX9 in non‐small cell lung cancer
Chen, W., Zhao, W., Chen, S., Zhang, L., Guo, Z., Wang, L., Wang, J., Wan, Z., Hong, Y., & Yu, L. (2018) · The Clinical Respiratory Journal · doi:10.1111/crj.12906 · Cited by 31
Reglődi, D., Cseh, S., Somoskői, B., Fulop, B. D., Szentléleky, E., Szegeczki, V., Kovács, A., Varga, A., Kiss, P., Hashimoto, H., et al. (2017) · Reproduction · doi:10.1530/rep-17-0470 · Cited by 29
“Loss of function of Sox10 had no effect on testis development (Barrionuevo & Scherer 2010) but a crossregulation has been proven between Sox9 and Sox10 in other cells, such as melanocytes (Shakhova et al. 2015).”
BackgroundSubhadarshini, S., Sahoo, S., Debnath, S., Somarelli, J. A., & Jolly, M. K. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-006766 · Cited by 33
Durand, S., Tang, Y., Pommier, R. M., Benboubker, V., Grimont, M., Boivin, F., Barbollat‐Boutrand, L., Cumunel, E., Dupeuble, F., Eberhardt, A., et al. (2024) · Oncogene · doi:10.1038/s41388-024-03010-7 · Cited by 29
“Analysis of SOX10 and SOX9 expression [28] (Fig.”
BackgroundSystems analysis identifies miR-29b regulation of invasiveness in melanoma
Andrews, M. C., Cursons, J., Hurley, D., Anaka, M., Cebon, J. S., Behren, A., & Crampin, E. J. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0554-y · Cited by 29
“A SOX10-low state is associated with reduced cell proliferation and engagement of EMT-like processes in melanoma to promote more invasive phenotypes [55] - a state maintained, in part, through mutual-antagonism with the closely re-lated transcription factor SOX9 [56].”
BackgroundInfluentialMertelmeyer, S., Weider, M., Baroti, T., Reiprich, S., Fröb, F., Stolt, C. C., Wagner, K., & Wegner, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-74664-y · Cited by 26
Self-citationEpigenetics Regulates Antitumor Immunity in Melanoma
Chen, Y., Yi, X., Sun, N., Guo, W., & Li, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.868786 · Cited by 27
Yang, X., Hu, F., Liu, J. A., Yu, S., Cheung, M. P. L., Liu, X., Ng, I. O., Guan, X., Wong, K. K. W., Sharma, R., et al. (2020) · Oncogene · doi:10.1038/s41388-020-1274-8 · Cited by 26
Program, N. C. S., Fufa, T., Baxter, L. L., Wedel, J. C., Gildea, D. E., Loftus, S. K., & Pavan, W. J. (2019) · Epigenetics & Chromatin · doi:10.1186/s13072-019-0297-2 · Cited by 40
Metastatic melanoma moves on: translational science in the era of personalized medicine
Levesque, M. P., Cheng, P. F., Raaijmakers, M. I. G., Saltari, A., & Dummer, R. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9658-0 · Cited by 25
Self-citationThe Role of SOX9 in IGF-II-Mediated Pulmonary Fibrosis
Waldrep, K. M., Rodgers, J. I., Garrett, S. M., Wolf, B. J., & Feghali‐Bostwick, C. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411234 · Cited by 22
Gambichler, T., Petig, A.-L., Stockfleth, E., & Stücker, M. (2016) · Clinical and Experimental Dermatology · doi:10.1111/ced.12928 · Cited by 21
SOX10 , MITF , and microRNAs : Decoding their interplay in regulating melanoma plasticity
Lai, X., Luan, C., Zhang, Z., Wessely, A., Heppt, M. V., Berking, C., & Vera, J. (2025) · International Journal of Cancer · doi:10.1002/ijc.35499 · Cited by 17
“…NRAS oncogene expression, and importantly, even partial reduction of SOX10 (haploinsufficiency) significantly impedes tumor cell proliferation, 48,49 suggesting a potential therapeutic window where partial inhibition might achieve clinical benefit without complete disruption of normal melanocyte…”
Su, Z., Zheng, X., Zhang, X., Wang, Y., Zhu, S., Lu, F., Qu, J., & Hou, L. (2016) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2016.12.002 · Cited by 20
Law, V., Chen, Z., Vena, F., Smalley, I., Macaulay, R. J. B., Evernden, B. R., Tran, N., Piña, Y., Puskas, J., Cáceres, G., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac054 · Cited by 18
Sox9 facilitates proliferation, differentiation and lipogenesis in primary cultured human sebocytes
Shi, G., Wang, T., Quan, J., Li, S., Zhang, M., Liao, P.-Y., & Fan, Y. (2016) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2016.10.005 · Cited by 17
Kyriakou, G., & Melachrinou, M. (2020) · Future Oncology · doi:10.2217/fon-2020-0151 · Cited by 19
CEACAM1 is a direct SOX10 target and inhibits melanoma immune infiltration and stemness
Abou‐Hamad, J., Hodgins, J. J., de Souza, C. T., Garland, B., Labrèche, C., Marotel, M., Gibson, C., Delisle, S., Pascoal, J., Auer, R. C., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105524 · Cited by 17
“7 cells following transduction with pBABE-Sox10.”
InfluentialScrotal angiokeratoma (Fordyce): histopathological and ultrastructural findings.
Gioglio, L., Porta, C., Moroni, M., Nastasi, G., & Gangarossa, I. (1992) · PubMed · Cited by 18
PITX1 inhibits the growth and proliferation of melanoma cells through regulation of SOX family genes
Ohira, T., Nakagawa, S., Takeshita, J., Aburatani, H., & Kugoh, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-97791-6 · Cited by 17
Opposing Roles of JNK and p38 in Lymphangiogenesis in Melanoma
Puujalka, E., Heinz, M., Hoesel, B., Friedl, P., Schweighofer, B., Wenzina, J., Pirker, C., Schmid, J. A., Loewe, R. P., Wagner, E. F., et al. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.01.020 · Cited by 16
“For VEGF-C, MITF, sex determining region Y-box 10 (SOX10), and SOX9 genes, the correlation analysis based on microarrays was confirmed by RT-PCR (Supplementary Figure S1c).”
BackgroundInfluentialHassel, L. A., Fröb, F., Küspert, M., Hillgärtner, S., Arnold, P., Huang, W., Kirchhoff, F., & Wegner, M. (2023) · Glia · doi:10.1002/glia.24373 · Cited by 15
“…there have also been reports on cross-regulation and functional antagonism between both proteins in oligodendroglial cells and other cells outside the CNS, arguing that their relationship is more complicated (John et al., 2011; Reiprich et al., 2017; Shakhova et al., 2015; Wahlbuhl et al., 2011).”
BackgroundSelf-citationDormancy of cutaneous melanoma
Singvogel, K., & Schittek, B. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03278-5 · Cited by 17
“Intriguingly, loss of SOX10 leads to SOX9 upregulation in an antagonistic fashion [78].”
BackgroundSOX10 mediates glioblastoma cell-state plasticity
Man, K.-H., Wu, Y., Gao, Z., Spreng, A., Keding, J., Mangei, J., Boskovic, P., Mallm, J., Liu, H., Imbusch, C. D., et al. (2024) · EMBO Reports · doi:10.1038/s44319-024-00258-8 · Cited by 15
“This antagonistic relationship between SOX10 and SOX9 also appears to extend to other cancers, i.e., resulting in melanoma progression upon reduced expression of SOX10 (Shakhova et al, 2015; Tsoi et al, 2018).”
Ding, X., Wang, L., Chen, M., Wu, Y., Ge, S., Li, J., Fan, X., & Lin, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.610683 · Cited by 14
Expression and localization of Sox10 during hair follicle morphogenesis and induced hair cycle
Jing, J., Xu, P., Xu, J., Ding, Y., Yang, X., Jin, X., Zhou, L.-J., Chen, Y., Wu, X., & Lu, Z. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.60728 · Cited by 13
Sox9 regulates melanocytic fate decision of adult hair follicle stem cells
Stüfchen, I., Beyer, F., Staebler, S., Fischer, S., Kappelmann‐Fenzl, M., Beckervordersandforth, R., & Bosserhoff, A. (2023) · iScience · doi:10.1016/j.isci.2023.106919 · Cited by 14
“Still, its role in adult McSCs and mature melanocytes in the HF is controversially discussed as two studies report contradictory findings regarding Sox9 expression in HF melanocytic cells.(20,21) In this study, we aimed to determine the role of Sox9 in distinct developmental steps within the melanocytic lineage of adu…”
BackgroundYu, L., Fan, P., Dong, X., Chen, Y., Sun, D., Jiang, S., & Deng, C. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.564740 · Cited by 14
Lineage-restricted sympathoadrenal progenitors confer neuroblastoma origin and its tumorigenicity
Yang, C.-L., Serra‐Roma, A., Gualandi, M., Bodmer, N., Niggli, F. K., Schulte, J. H., Bode, P. K., & Shakhova, O. (2020) · Oncotarget · doi:10.18632/oncotarget.27636 · Cited by 11
“Sox9, another member of SoxE family of transcription factors, plays a crucial role in NC development [31].”
BackgroundSelf-citationPigment Cell Development in Teleosts
Hashimoto, H., Goda, M., & Kelsh, R. N. (2021) · Springer eBooks · doi:10.1007/978-981-16-1490-3_7 · Cited by 14
An in vivo avian model of human melanoma to perform rapid and robust preclinical studies
Jarrosson, L., Dalle, S., Costechareyre, C., Tang, Y., Grimont, M., Plaschka, M., Lacourrège, M., Teinturier, R., Bouar, M. L., Maucort‐Boulch, D., et al. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202216629 · Cited by 10
“We then wondered whether exposure of melanoma cells to this particular embryonic microenvironment could have modified the expression of key actors of the SOX10-MITF axis, well described to be involved in melanomagenesis (Capparelli et al, 2022; Shakhova et al, 2015; Cheli et al, 2011).”
BackgroundKanai, M., Shinagawa, A., Ota, M., Virgona, N., & Yano, T. (2024) · Anticancer Research · doi:10.21873/anticanres.17356 · Cited by 9
“Additionally, SOX9 is expressed in cells derived from neural crest cells, including melanocytes, and expression is said to decrease in the order of melanocytes, nevi, primary malignant melanoma, and metastatic MM (51).”
CEACAM1: Expression and Role in Melanocyte Transformation
Turcu, G., Nedelcu, R., Ion, D. A., Brînzea, A., Cioplea, M. D., Jilaveanu, L. B., & Zurac, S. (2016) · Disease Markers · doi:10.1155/2016/9406319 · Cited by 8
“Also, MITF binds the CEACAM1 promoter on an M-box motif, thus directly stimulating CEACAM1 expression [45].”
BackgroundInfluentialp300 KAT Regulates SOX10 Stability and Function in Human Melanoma
Waddell, A. R., Grbic, N., Leibowitz, K., Wyant, W. A., Choudhury, S., Park, K., Collard, M., Cole, P. A., & Alani, R. M. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-24-0124 · Cited by 9
Copy number variation in archival melanoma biopsies versus benign melanocytic lesions
Mahas, A., Potluri, K., Kent, M. N., Naik, S., & Markey, M. P. (2016) · Cancer Biomarkers · doi:10.3233/cbm-160600 · Cited by 7
“Sox9 has been shown to induce cell cycle arrest and apoptosis in melanoma via antagonism of Sox10 [167].”
BackgroundSOX9 Protein in Pancreatic Cancer Regulates Multiple Cellular Networks in a Cell-Specific Manner
Kopantzev, E. P., Kondratyeva, L. G., Kopantseva, M. R., Кашкин, К. Н., Gnatenko, D. A., Grigorieva, E., Алексеенко, И. В., Safina, D. R., & Чернов, И. П. (2022) · Biomedicines · doi:10.3390/biomedicines10071466 · Cited by 6
Human cutaneous interfollicular melanocytes differentiate temporarily under genotoxic stress
Fessé, P., Nyman, J., Hermansson, I., Book, M., Ahlgren, J., & Turesson, I. (2022) · iScience · doi:10.1016/j.isci.2022.105238 · Cited by 5
Neural Crest Cell Diversification and Specification: Melanocytes☆
Bismuth, K., Debbache, J., Sommer, L., & Arnheiter, H. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.02619-5 · Cited by 5
Self-citationHuman Oral Mucosa as a Potentially Effective Source of Neural Crest Stem Cells for Clinical Practice
Bardag‐Gorce, F., Dahan, M. A., Narwani, K., Terrazas, J., Ferrini, M. G., Calhoun, C. C., Uyanne, J., Royce-Flores, J., Crum, E., & Niihara, Y. (2023) · Cells · doi:10.3390/cells12182216 · Cited by 4
“The expression of SOX10 was found to be low in the experimental cells, probably because SOX9 was expressed, causing an inhibitory effect on SOX10 expression [53].”
BackgroundOverview of chromatin regulatory processes during surface ectodermal development and homeostasis
Branch, M. C., Weber, M., Li, M.-Y., Flora, P., & Ezhkova, E. (2024) · Developmental Biology · doi:10.1016/j.ydbio.2024.07.001 · Cited by 5
Atrazine modifies markers of melanocyte maturation and apoptosis in primary skin cultures
González-Palomo, A. K., Ruiz-Rodríguez, V. M., Hernández‐Blanco, D., Pérez‐Vázquez, F. J., Alcántara-Quintana, L. E., & Cortés-García, J. D. (2022) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2022.2124135 · Cited by 3
“…in the activation of the anti-tumorigenic program by inhibiting the expression of SOX-10 and the cell adhesion molecule of carcinoembryonic antigen 1 (CEACAM1), an important glycoprotein in the resistance to the immune response against melanoma cells (Shakhova et al. 2015; Ashkenazi et al. 2016).”
BackgroundSox2 Functions in Neural Cancer Stem Cells: The Importance of the Context
Barone, C., Pagin, M., Serra, L., Alessia, M., Rigoldi, L., Simone, G., Sanga, A. B., Mercurio, S., & Nicolis, S. K. (2018) · Insights of Neuro Oncology · doi:10.36959/828/332 · Cited by 3
Melanocyte stem cells in skin diseases and their potential in cell-based therapy.
Wang, Z., Liu, L., & Zheng, Y. (2022) · PubMed · doi:10.14670/hh-18-470 · Cited by 7
LncRNAs in CONDBITs Perspectives, From Genetics towards Theranostics
Anurogo, D., Parikesit, A. A., & Ikrar, T. (2019) · Jurnal Sains Kesihatan Malaysia · doi:10.17576/jskm-2019-1702-01 · Cited by 3
Misek, S., Appleton, K. M., Dexheimer, T. S., Lisabeth, E. M., Lo, R. S., Larsen, S. D., Gallo, K., & Neubig, R. R. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/381806 · Cited by 3
Zhang, Y., Riedstra, C. P., Wang, S., Patel, S. A., Bald, T., Kumar, P., Rohani, A., Kashatus, D. F., Moschos, S. J., & Dudley, A. C. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.15.500231 · Cited by 3
Sun, X., Cheng, Y., Sun, M.-W., Zhang, X., Yu, X., Wang, H., Wang, Y., & Li, N. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1444670 · Cited by 2
SOXs: Master architects of development and versatile emulators of oncogenesis
Saloni, Sachan, M., Rahul, Verma, R. S., & Patel, G. K. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189295 · Cited by 2
Yang, F., Yang, L., Lai, S., Yokota, M., Kuroda, Y., Yuki, T., Takahashi, Y., Sayo, T., Namiki, T., Goto, H., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-72064-w · Cited by 4
“SOX9 also antagonizes SOX10 43 , a master regulator of melanocyte differ-entiationviaMITFactivation 44 ,andplaysacriticalroleinprecursorfate determination in the hair follicle niche 45 .”
Li, L., Cao, H., Yang, J., Ma, Y., Jin, T., Wang, Y., Li, Z., Chen, Y., Gao, H., Zhu, C., et al. (2023) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2200692 · Cited by 3
“Sex-determining region Y-box protein 9 (Sox9) is expressed in keratino‐ cytes, sebaceous glands, sweat glands, and melano‐ cytes (Vidal et al., 2008; Shi et al., 2013; Shakhova et al., 2015).”
BackgroundBogusławska-Duch, J., Ducher-Hanaka, M., Zajkowska, A., Czajka, M., & Małecki, M. (2021) · PubMed Central · doi:10.5114/ada.2021.110461 · Cited by 1
Developmental Biology of Melanocytes
Sommer, L. (2017) · Springer eBooks · doi:10.1007/978-1-4614-7322-0_23-1 · Cited by 3
Self-citationDeciphering of SOX9 Functions in Pancreatic Cancer Cells
Кашкин, К. Н., Kondratyeva, L. G., Kopantzev, E. P., Abramov, I. S., Zhukova, L., & Чернов, И. П. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062652 · Cited by 1
“Conversely, SOX9 itself has been shown to play a suppressor role in cervical cancer [12], endometrial carcinoma [13], melanoma [14], and certain intestinal tumors [15].”
Impact of texturing on sliding wear behaviour of UHMWPE
Eddoumy, F. (2012) · theses.fr (ABES) · doi:10.70675/8db88ecczf223z441bz8f27z896478d1faf3 · Cited by 4
Melanoma cell states define therapeutic vulnerabilities in a multimodal single-cell atlasPreprint
Levesque, M. P., Wegmann, R., Chevrier, S., Lehmann, K.-V., Prummer, M., Tusup, M., Gut, G., Casanova, R., Kuipers, J., Lischetti, U., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9413884/v1 · Cited by 2
Self-citationMahas, A. (2015) · CORE Scholar (Wright State University)
Regulation and Function of the Cancer Stem Cell Transcription Factors GLI1 and Kruppel-like Factor 4
Vanderbilt, D. B. (2015) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.6863
Venkatesan, A. M. (2017) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m20386
The Role of the Ste20-like Kinase in Embryonic Development and Neu-induced Mammary Tumorigenesis
Al‐Zahrani, K. N. (2018) · uO Research (University of Ottawa) · doi:10.20381/ruor-22866 · Cited by 1
“Although some reports corroborate the findings that Sox9 can induce Sox10 expression, some studies report that these two proteins repress each other’s expression, suggesting that perhaps this regulation is context dependent (165,190,191).”
BackgroundResultVoronkova, M. A. (2019) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.4075
Wong, T. C. (2018) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Amiri, R., Tafvizi, F., & Ghanadan, A. (2020) · Gene Reports · doi:10.1016/j.genrep.2020.100848
Classification and Grading of Melanocytic Lesions in a Mouse Model of NRAS -driven Melanomagenesis
Assenmacher, C., Santagostino, S. F., Oyama, M. A., Marine, J., Bonvin, E., & Radaelli, E. (2020) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155420977970
Developmental Biology of Melanocytes
Sommer, L. (2019) · Springer eBooks · doi:10.1007/978-1-4614-7147-9_23
Self-citationAshton, D. T. (2019) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17135201
Kramer, E. T., Godoy, P. M., & Kaufman, C. K. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.05.519210
Metadata
- Authors
- Shakhova, O., Cheng, P., Mishra, P. J., Zingg, D., Schaefer, S. M., Debbache, J., Häusel, J., Matter, C., Guo, T., Davis, S., Meltzer, P., Mihic-Probst, D., Moch, H., Wegner, M., Merlino, G., Levesque, M. P., Dummer, R., Santoro, R., Cinelli, P., & Sommer, L.
- Affiliations
- University of Zurich (CH)
- University Hospital Zurich (CH)
- National Institutes of Health (US)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Corresponding author
- Sommer, Lukas
- ORCID
- Venue
- PLOS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-01-28
- Volume
- 11
- Issue
- 1
- Pages
- e1004877
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC4309598
- OpenAlex
- W2052814985
- Cited by
- 111
- References
- 63
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 7 · 2023: 9 · 2022: 13 · 2021: 9 · 2020: 11 · 2019: 12 · 2018: 7 · 2017: 11 · 2016: 15 · 2015: 3
- FWCI
- 5.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- public-domain
- creativecommons.org/publicdomain/zero/1.0/ (vor)
- Locations
- PLoS Genetics (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, public-domain)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, public-domain)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Universität Zürich
- Promedica Stiftung
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
- Keywords
- melanoma, SOX9, SOX10, transcription factor antagonism, cross-regulation, cell cycle arrest, apoptosis, melanocyte stem cells, feedback loops, tumor suppression
- MeSH terms
- Animals, Humans, Melanocytes, Melanoma, Gene Expression Regulation, Neoplastic, Apoptosis, Hair Follicle, RNA, Small Interfering, Cell Line, Tumor, Mice, SOXE Transcription Factors, SOX9 Transcription Factor, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.